DE69407668D1 - Verwendung van Acyl-L-Carnitin-gamma-hydroxybutyraten zur Herstellung eines Arzneimittels zur Behandlung der Drogenabhängigkeit - Google Patents

Verwendung van Acyl-L-Carnitin-gamma-hydroxybutyraten zur Herstellung eines Arzneimittels zur Behandlung der Drogenabhängigkeit

Info

Publication number
DE69407668D1
DE69407668D1 DE69407668T DE69407668T DE69407668D1 DE 69407668 D1 DE69407668 D1 DE 69407668D1 DE 69407668 T DE69407668 T DE 69407668T DE 69407668 T DE69407668 T DE 69407668T DE 69407668 D1 DE69407668 D1 DE 69407668D1
Authority
DE
Germany
Prior art keywords
acyl
gamma
carnitine
hydroxybutyrate
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69407668T
Other languages
English (en)
Other versions
DE69407668T2 (de
Inventor
Giovanni Scapagnini
Claudio Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of DE69407668D1 publication Critical patent/DE69407668D1/de
Application granted granted Critical
Publication of DE69407668T2 publication Critical patent/DE69407668T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69407668T 1993-06-24 1994-06-20 Verwendung van Acyl-L-Carnitin-gamma-hydroxybutyraten zur Herstellung eines Arzneimittels zur Behandlung der Drogenabhängigkeit Expired - Fee Related DE69407668T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930412A IT1261485B (it) 1993-06-24 1993-06-24 Uso di acil l-carnitine gamma-idrossibutirrato per il trattamento di tossicodipendenze.

Publications (2)

Publication Number Publication Date
DE69407668D1 true DE69407668D1 (de) 1998-02-12
DE69407668T2 DE69407668T2 (de) 1998-04-16

Family

ID=11401821

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69407668T Expired - Fee Related DE69407668T2 (de) 1993-06-24 1994-06-20 Verwendung van Acyl-L-Carnitin-gamma-hydroxybutyraten zur Herstellung eines Arzneimittels zur Behandlung der Drogenabhängigkeit

Country Status (9)

Country Link
EP (1) EP0630648B1 (de)
JP (1) JPH0733654A (de)
AT (1) ATE161719T1 (de)
DE (1) DE69407668T2 (de)
DK (1) DK0630648T3 (de)
ES (1) ES2111890T3 (de)
GR (1) GR3026443T3 (de)
HK (1) HK1005902A1 (de)
IT (1) IT1261485B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2383673T3 (es) 2000-09-22 2012-06-25 Jpi Commercial, Llc Composiciones de gamma-hidroxibutirato que contienen portadores de hidrato de carbonos
WO2021211540A1 (en) * 2020-04-14 2021-10-21 The Regents Of The University Of California Diagnosis and treatment of addiction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1217783B (it) * 1988-06-03 1990-03-30 Farmaceutico Ct S R L Lab Impiego di salo dell,acido gamma idrossi butirrico per la preparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell,alcolismo e composizioni relative
IT1248321B (it) * 1991-05-15 1995-01-05 Sigma Tau Ind Farmaceuti Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie

Also Published As

Publication number Publication date
ITRM930412A1 (it) 1994-12-24
IT1261485B (it) 1996-05-23
EP0630648B1 (de) 1998-01-07
ES2111890T3 (es) 1998-03-16
ATE161719T1 (de) 1998-01-15
ITRM930412A0 (it) 1993-06-24
GR3026443T3 (en) 1998-06-30
DK0630648T3 (da) 1998-09-07
DE69407668T2 (de) 1998-04-16
JPH0733654A (ja) 1995-02-03
HK1005902A1 (en) 1999-01-29
EP0630648A1 (de) 1994-12-28

Similar Documents

Publication Publication Date Title
WO2000044361A3 (en) Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders
ES2181673T3 (es) Procedimiento de tratamiento de las enfermedades respiratorias infecciosas.
DE122005000002I1 (de) Verwendung von Venlafaxin oder eines Aryloxy-Propanaminderivates zur Herstellung eines Medikaments zur Behandlung von Inkontinenz.
ATE332702T1 (de) Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen
ATE184193T1 (de) Verwendung von n-acylaminoalkoholen zur herstellung eines arzneimittels zur behandlung von mastzellerkrankungen
ATE141505T1 (de) Verwendung von 3-guanidinopropionsäure zur herstellung eines medikaments zur behandlung und prävention von fettsucht
DE69934813D1 (de) Verwendung von gaba analogen zur herstellung eines arzneimittels zur behandlung von manie und bipolaren erkrankungen
NO176082C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende bunazosin, for perkutan tilförsel
DE69327286D1 (de) Verfahren zur Herstellung eines Fettsäureesters von Cellulose
DE3751036D1 (de) Durch Carnitin dirigierte pharmazeutische Substanzen und ihre Verwendung zur Herstellung eines Arzneimittels zur Behandlung von Muskelerkrankungen.
DE68924714D1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
ATE206914T1 (de) Verwendung von ursolsäure zur herstellung eines arzneimittels zur unterdrückung von metastasen
EP0315113A3 (de) Innere Ester von Gangliosiden mit analgetisch-entzündungshemmender Aktivität
DE69407668D1 (de) Verwendung van Acyl-L-Carnitin-gamma-hydroxybutyraten zur Herstellung eines Arzneimittels zur Behandlung der Drogenabhängigkeit
DE69735870D1 (de) Verwendung von Aminosäuren zur Herstellung eines Arzneimittels zur Hemmung oder Aktivierung von Glutaminsäure im Gehirn
IT8948475A0 (it) Estere della l-carnitina con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che lo contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma
DE69207479D1 (de) Verwendung der Ester von Acyl-L-Carnitin mit Gamma-Hydroxy-Buttersäure zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Lebererkrankungen
CA2280940A1 (en) Use of plant extract for inhibition of haemophilus influenzae
ATE96025T1 (de) Verwendung von dapiprazol zur herstellung eines arzneimittels zur verhinderung des toleranzentwicklung bei der analgetischen behandlung mit morphin.
ATE85521T1 (de) Verwendung von acetyl-l-carnitin zur herstellung eines arzneimittels zur therapeutischen behandlung von schockzustaenden.
DE3751261D1 (de) Verfahren zur Herstellung eines Kohlensäureesters.
DE69610045D1 (de) Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen
ATE118348T1 (de) Liposome hoher stabilität und verfahren zur herstellung und verwendung.
ATE167056T1 (de) Verwendung von ester von acyl-l-carnitin mit gammahydroxybuttersäure zur behandlung von alkoholismus
DE69632117D1 (de) Verwendung von 8,9-Dehydroestron zur Herstellung eines Arzneimittels zur Behandlung von durch freie Radikale verursachte Krankheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee